4//SEC Filing
ORTH ANDREW C. 4
Accession 0000925421-21-000140
CIK 0001711279other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:19 PM ET
Size
5.7 KB
Accession
0000925421-21-000140
Insider Transaction Report
Form 4
ORTH ANDREW C.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-31+205,000→ 205,000 totalExercise: $65.24Exp: 2031-05-31→ Common Stock (205,000 underlying)
Holdings
- 100
Common Stock
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on May 3, 2022.
Documents
Issuer
Krystal Biotech, Inc.
CIK 0001711279
Entity typeother
Related Parties
1- filerCIK 0001860010
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 7:19 PM ET
- Size
- 5.7 KB